NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
TOUR
Tuniu Corporation
There isn't enough reported data to score TOUR yet.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
TOUR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Healthy |
TOUR's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
TOUR PE Valuation
TOUR has no meaningful PE right now: it lost money over the past year.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
TOUR Forward outlook
There aren't enough analyst estimates for TOUR to show an outlook.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
TOUR Earnings Per Share
TOUR and NKE do not have enough comparable growth data to identify a winner.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
TOUR has the stronger quarterly revenue trend. Revenue is down 4.3% for NKE versus up 13% for TOUR.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
TOUR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $19.9M | +13% |
| Q4 2025 | $18.5M | +20% |
| Q3 2025 | $30.3M | +8.6% |
| Q2 2025 | $20.2M | +15% |
| Q1 2025 | $17.6M | +8.9% |
| Q4 2024 | $15.4M | +2.8% |
| Q3 2024 | $27.9M | +4.4% |
| Q2 2024 | $17.5M | +17% |
TOUR's revenue has grown year over year for 13 quarters in a row: $20M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -2.8% | +6.4 points |
| Q4 2025 | 0.9% | +13 points |
| Q3 2025 | 6.8% | -8.8 points |
| Q2 2025 | 5.3% | -24 points |
| Q1 2025 | -9.2% | -21 points |
| Q4 2024 | -12% | +111 points |
| Q3 2024 | 16% | -2.1 points |
| Q2 2024 | 29% | +23 points |
TOUR's operating margin was −2.8% last quarter, up 6.4 points from the same quarter a year ago.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE has the stronger cash trend. Its trailing FCF is down 52% versus its history, compared with TOUR at down 100%.
TOUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | -100% |
| Q2 2024 | $0 | -100% |
| Q1 2024 | $0 | -100% |
| Q4 2023 | $0 | -100% |
| Q3 2023 | $250.5K | -44% |
TOUR's free cash flow has been positive every quarter since mid-2020: $0 over the past year, against $250,463 the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
TOUR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.3% | -88.5K shares |
| 1 year | -5.8% | -230K shares |
TOUR has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
TOUR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.8x | Net Cash |
| Q4 2025 | -3.2x | Net Cash |
| Q3 2025 | -34.6x | Net Cash |
| Q2 2025 | -14.7x | Net Cash |
| Q1 2025 | -16.8x | Net Cash |
| Q4 2024 | -5.9x | Net Cash |
| Q3 2024 | -3.8x | Net Cash |
| Q2 2024 | -6.7x | Net Cash |
TOUR has more cash than debt.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
TOUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 12.5 | Oversold |
TOUR's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
TOUR PE vs Consumer Cyclical Sector
TOUR has no meaningful PE right now: it lost money over the past year.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over TOUR on trend strength, trading above more of its moving averages.
TOUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.86 | 3.5% below |
| 20 week MA | $4.95 | 5.3% below |
| 50 week MA | $5.94 | 21% below |
| 100 week MA | $7.53 | 38% below |
| 200 week MA | $9.63 | 51% below |
TOUR is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
TOUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.5 | $19.2 | -18% |
| 2021 | $19.2 | $9.78 | -49% |
| 2022 | $9.78 | $16.7 | +71% |
| 2023 | $16.7 | $6.71 | -60% |
| 2024 | $6.71 | $9.85 | +47% |
| 2025 | $9.85 | $7.25 | -26% |
| 2026 YTD | $7.25 | $4.69 | -35% |
TOUR has the edge over NKE on returns for 2026, with the stronger performance.